• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussion
  • Groups
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussion
    • Groups
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Private Equity

    ‘Super Site’ Velocity Clinical Research Acquired by European Private Equity Site Transformations Goes to the Next Level

    ‘Super Site’ Velocity Clinical Research Acquired by European Private Equity: Site Transformations Goes to the Next Level

    Rapid growth in any business certainly attracts positive attention and in the world of clinical research trial sites even more so as scale becomes ever…

    TrialSite Staff
    TrialSite Staff April 8, 2021
    0 Comments
    Velocity Clinical Research Strategic Move to Diversity Patient Enrollment Options Southern California eStudySite Acquisition

    Velocity Clinical Research Strategic Move to Diversify Patient Enrollment Options: Southern California eStudySite Acquisition

    Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to its North American site portfolio,…

    TrialSite Staff
    TrialSite Staff November 13, 2020
    0 Comments
    Blackstone Raises Largest Life Sciences PEG Fund in History & Already Putting Capital to Work Should Big Pharma be Nervous

    Blackstone Raises Largest Life Sciences PEG Fund in History & Already Putting Capital to Work: Should Big Pharma be Nervous?

    Blackstone has raised more all purpose investment funds than another other private equity group in the United States.  With the closing of Blackstone Life Sciences…

    TrialSite Staff
    TrialSite Staff July 13, 2020
    0 Comments
    Cowen Raises $493 Healthcare Funding & Looking for Disruptive Life Science Targets

    Cowen Raises $493 Healthcare Funding & Looking for Disruptive Life Science Targets

    A new private equity health care fund with an emphasis on life sciences evidences the healthy investor appetite for health and life science-related activities. Cowen…

    TrialSite Staff
    TrialSite Staff May 23, 2020
    0 Comments
    Advarra buys Boutique IRB as PEG-Backed, Consolidators Push Ahead in COVID-19 World

    Advarra buys Boutique IRB as PEG-Backed, Consolidators Push Ahead in COVID-19 World

    Central institutional review board (IRB) consolidator Advarra has acquired another firm—this time a boutique IRB firm called IRBco. This purchase represents the ongoing march of…

    TrialSite Staff
    TrialSite Staff April 22, 2020
    0 Comments
    CenExel Acquires Research Centers of America further Expanding Its Operation Across the Country

    CenExel Acquires Research Centers of America further Expanding Its Operation Across the Country

    Clinical research site expansion continues at a healthy rate as CenExel Clinical Research, Inc. (“CenExel”) acquires Research Centers of America (RCA), a Hollywood, Florida based clinical investigational…

    TrialSite Staff
    TrialSite Staff December 5, 2019
    0 Comments
    One of the World’s Largest Private Equity Firms Enters Targets Unmet Need for Bladder Cancer with Swiss Pharma

    One of the World’s Largest Private Equity Firms Enters Targets Unmet Need for Bladder Cancer with Swiss Pharma

    Private equity giant Blackstone, the world’s third largest private equity investor, continues to move deeper into the life sciences vertical pairing with Ferring Pharmaceuticals to ink…

    TrialSite Staff
    TrialSite Staff November 25, 2019
    0 Comments
    More Private Equity Moving into Clinical Trials Services Showcasing the Importance and Value of the Industry

    More Private Equity Moving into Clinical Trials Services Showcasing the Importance and Value of the Industry

    Private equity continues to become more intrigued by clinical trials. From investing in clinical investigational sites to services providers to disruptive technologies, funds are seeking…

    TrialSite Staff
    TrialSite Staff November 16, 2019
    0 Comments

    Nationwide Clinical Investigational Site Consolidation Continues with CNS-Focused Consolidation Funded by Bison Capital Partners

    In yet another private equity-backed consolidation move in the clinical research site market, private equity made a power move again, this time underwriting a new…

    TrialSite Staff
    TrialSite Staff October 9, 2019
    0 Comments
    Female medicine doctor shake hand as hello

    Medicxi Ventures Closed a New 400 Euro Fund to Power the Next Wave of Biopharma Entrepreneurs & Drug Hunters

    Medicxi Introduces the €400 Medicxi III fund, closed in just six weeks, and brings the total funds raised in the last three years to over…

    TrialSite Staff
    TrialSite Staff July 20, 2019
    0 Comments
    Load More

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.